Comment on Beato-Víbora et al. A Multicenter Prospective Evaluation of the Benefits of Two Advanced Hybrid Closed-Loop Systems in Glucose Control and Patient-Reported Outcomes in a Real-World Setting. Diabetes Care 2024;47:216–224.

The article discusses research by Maha Lebbar, Zoé Henry, and Charles Thivolet, reported in the Diabetes Care issue focusing on topics such as the comparison of glucose control and patient-reported outcomes after initiation of advanced hybrid closed-loop (AHCL) insulin delivery systems (Medtronic SmartGuard 780G and Tandem T-Slim Control-IQ), differences in continuous glucose monitoring outcomes between AHCL systems, and the impact of age on glucose efficacy.